Effect of soluble interleukin-6 receptor α and interleukin-6 secreted by polymorphonuclear leukocytes on tumor necrosis factor-α expression and its production by peripheral blood mononuclear cells

Mediators of Inflammation

Volumn 11, Issue 5, 2002, Pages 325-328

  Jablonska, E ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Interleukin 6; Peripheral blood mononuclear cells; Polymorphonuclear cells; Soluble interleukin 6 receptor; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; HYBRID PROTEIN; INTERLEUKIN 6 INTERLEUKIN 6 RECEPTOR FUSION PROTEIN, RECOMBINANT; INTERLEUKIN 6-INTERLEUKIN 6 RECEPTOR FUSION PROTEIN, RECOMBINANT; INTERLEUKIN RECEPTOR;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; MONONUCLEAR CELL; NEUTROPHIL; PRIORITY JOURNAL; CELL CULTURE; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; SECRETION; SOLUBILITY;

CELLS, CULTURED; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; NEUTROPHILS; RECEPTORS, INTERLEUKIN; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SOLUBILITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036810217     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350210000015746     Document Type: Article

References (15)

1. Cassatella MA, Gasperini S, Russo ME Cytokine expression and release by neutrophlis. Ann NY Acad Sci 1997; 15: 233-242.
2. Horiuchi S, Koyanagi Y, Zhou Y, et al. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated though an alternative splicing mechanism. Eur J Immunol 1994; 24: 1945-1948.
3. Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp 130. Blood 1995; 86: 1243-1254.
4. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei X-F Achong MK. IL-6 Is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101: 311-320.
5. Müllberg J, Oberthür W, Lottspeich F. et al. The soluble human IL-6 receptor. J Immunol 1994; 152: 4958-4968.
6. Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM. The soluble interleukin 6 receptor: Mechanisms of production and implications in disease. FASEB J 2001; 15: 43-58.
7. Modur V, Li Y, Zimmerman GA, Prescott SM, McIntyre TM. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest 1997; 100: 2752-2756.
8. Oh JW, Van Wagoner NJ, Rose-John S, Benveniste EN. Role of IL-6 and soluble IL-6 receptor in inhibition of VCAM-1 gene expression. J Immunol 1998; 161: 4992-4999.
9. Joyce DA, Steer JH. IL-4, IL-19 and IFN-γ have distinct, but interacting, effects on differentiation-induced changes in TNF-α and TNF receptor release by human monocytes. Cytokine 1996; 8: 49-56.
10. Abe Y, Osuka Y, Nakata T, Kashu Y, Kimura S. The functional role of 55-and 75-kDa tumor necrosis factor receptors in human polymorphonuclear cells in vitro. Cytokine 1995; 7: 39-49.
11. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990; 75: 40-47.
12. Igaz P, Horváth A, Horváth B, et al. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production, Immunol Lett 2000; 71: 143-148.
13. Galliard JP, Mani JC, Liautard J, Klein B, Brochier J. Intedeukin-6 receptor signaling. I. Gp80 and gpI30 receptor interaction in the absence of interleukin-6. Eur Cytokine Network 1999; 10: 43-48.
14. Jablonska E, Jablonski J. Effect of IL-18 on the release of IL-6 and its soluble receptors - sIL-6Rα and sgp 130 by human neutrophlls. Immunol Invest (2002) 31, 159-161.
15. Müller-Newen G, Küster A, Hermmann U, et al. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp 130 on IL-6 responses. J Immunol 1998; 161: 6347-6355.